Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_940e1f8479ac5bf42c2ea2652763176a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2018-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5697d48b669ef29abd43591a9adf6c1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a128998ac8c1b8af0d79da12edfdb981 |
publicationDate |
2018-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201834652-A |
titleOfInvention |
Method for treating cancer by farnesyl transferase (FARNESYLTRANSFERASE) inhibitor |
abstract |
The invention relates to the field of cancer therapy. In particular, the present invention provides a method for treating cancer (such as peripheral T-cell lymphoma (PTCL)) with a farnesyl transferase inhibitor (FTI), the method comprising based on gene expression Characteristics to determine whether the individual is likely to respond to the FTI treatment. |
priorityDate |
2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |